These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 29394022
1. Platinum(IV) Prodrugs. Venkatesh V, Sadler PJ. Met Ions Life Sci; 2018 Feb 05; 18():. PubMed ID: 29394022 [Abstract] [Full Text] [Related]
2. Anticancer platinum (IV) prodrugs with novel modes of activity. Chin CF, Wong DY, Jothibasu R, Ang WH. Curr Top Med Chem; 2011 Feb 05; 11(21):2602-12. PubMed ID: 22039869 [Abstract] [Full Text] [Related]
3. Platinum(iv) anticancer prodrugs - hypotheses and facts. Gibson D. Dalton Trans; 2016 Aug 16; 45(33):12983-91. PubMed ID: 27214873 [Abstract] [Full Text] [Related]
4. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions. Savino S, Marzano C, Gandin V, Hoeschele JD, Natile G, Margiotta N. Int J Mol Sci; 2018 Jul 14; 19(7):. PubMed ID: 30011897 [Abstract] [Full Text] [Related]
6. Advances in platinum chemotherapeutics. Harper BW, Krause-Heuer AM, Grant MP, Manohar M, Garbutcheon-Singh KB, Aldrich-Wright JR. Chemistry; 2010 Jun 25; 16(24):7064-77. PubMed ID: 20533453 [Abstract] [Full Text] [Related]
7. Pt(IV) Prodrug Photoactivation: A Promising Strategy for Cancer Therapy. Tang L, Luo Y, Luo W, Sun G, Jiang Y, Zhang Z, Yue X, Li S, Liang L, Liu W, Hu J. Curr Protein Pept Sci; 2024 Jun 25; 25(10):797-813. PubMed ID: 38919078 [Abstract] [Full Text] [Related]
8. Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery. Ma J, Wang Q, Huang Z, Yang X, Nie Q, Hao W, Wang PG, Wang X. J Med Chem; 2017 Jul 13; 60(13):5736-5748. PubMed ID: 28603992 [Abstract] [Full Text] [Related]
12. Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs. Marsh JW, Hacker L, Huang S, Boulet MHC, White JRG, Martin LAW, Yeomans MA, Han HH, Diez-Perez I, Musgrave RA, Hammond EM, Sedgwick AC. Dalton Trans; 2024 Sep 10; 53(35):14811-14816. PubMed ID: 39169877 [Abstract] [Full Text] [Related]
13. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy. Najjar A, Rajabi N, Karaman R. Curr Pharm Des; 2017 Sep 10; 23(16):2366-2376. PubMed ID: 28155621 [Abstract] [Full Text] [Related]
14. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules. Babu T, Sarkar A, Karmakar S, Schmidt C, Gibson D. Inorg Chem; 2020 Apr 06; 59(7):5182-5193. PubMed ID: 32207294 [Abstract] [Full Text] [Related]
18. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance. Chen Q, Yang Y, Lin X, Ma W, Chen G, Li W, Wang X, Yu Z. Chem Commun (Camb); 2018 May 22; 54(42):5369-5372. PubMed ID: 29744485 [Abstract] [Full Text] [Related]
19. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? Schmidt C, Babu T, Kostrhunova H, Timm A, Basu U, Ott I, Gandin V, Brabec V, Gibson D. J Med Chem; 2021 Aug 12; 64(15):11364-11378. PubMed ID: 34342437 [Abstract] [Full Text] [Related]
20. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid. Dabbish E, Ponte F, Russo N, Sicilia E. Inorg Chem; 2019 Mar 18; 58(6):3851-3860. PubMed ID: 30843385 [Abstract] [Full Text] [Related] Page: [Next] [New Search]